Cipla SWOT Analysis, Competitors & USP

Cipla

Parent Company

Cipla

Category

Pharmaceuticals

Sector

Pharma and Healthcare

Tagline/ Slogan

Caring for life

USP

Commitment to make medicines affordable and accessible particularly to cancer patients

Cipla STP

Segment

AIDS, respiratory disease, cancer cardiovascular disease, arthritis

Target Group

Customers of various flavors and fragrances, OTC products, prescription products, pesticides, agrochemicals, doctors

Positioning

They use latest technology to concentrate all their knowledge of over seven decades in developing life saving drugs

Cipla SWOT Analysis

Strengths

Below is the Strengths, Weaknesses, Opportunities & Threats (SWOT) Analysis of Cipla :

1. Cipla has developed good positive image by providing support to cancer patients by issuing drugs at low cost
2. Imminent commencement of the Fixed-Dose combination for treatment of uncomplicated P. falciparum malaria to tackle the 200+ million cases of malaria globally

3. Initiation of ‘No Touch Breast Scan’ a step forward in the screening technology in India.
4. A foremost player in anti-infective and anti-asthmatic formulations.
5. Has a strong employee force of over 16,000

Weaknesses

1. Strong competition from international and domestic giants means limited market share

2. Cipla had faced problems during negative campaign by AHF

Opportunities

1. It can venture into Alzheimer’s disease medication
2. They can use Viramune generic to achieve higher growth.

3. Increased investment in the budding markets, to push expansion in the global economy

Threats

1. Constant price rises in the Indian country is taking its toll and compounding the problem
2.The Indian Rupee depreciated as compared to the US Dollar

3. Fluctuations in currency exchange rates have a noteworthy impact on the Company’s operations and financial results.

Cipla Competition

Competitors

Below are the 4 main Cipla competitors :

1. Sun Pharmaceuticals
2. Dr. Reddy’s laboratories

3. Lupin

4. Ranbaxy labs